Activist investor takes cannabis action
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
You may have heard of activist investor Nelson Peltz. The billionaire (worth approximately $1.6 billion) is the founder of investment firm Trian Fund Management, which has more than $11 billion in assets under management.
Trian has a highly concentrated portfolio that includes stakes in Bank of New York Mellon, DuPont and food conglomerate Mondelez International.
If that didn’t make Peltz a busy man, add is his board positions with fast-food chain Wendy’s Co., Proctor & Gamble, food services giant Sysco Corp. and The Madison Square Garden Co.
That’s a wide variety of interests, which Peltz has been criticised for. He has also been accused of being adversarial as Trian push for changes in companies hey have invested in that will increase market value. Clearly, however, the opinions of others don’t matter much to him as the next vertical he chases is something that not long ago, wouldn’t have been a consideration.
Cannabis.
That’s right the hedge fund billionaire is endorsing a cannabis play and the market has reacted kindly.
Peltz will join Aurora (TSE:ACB), the $12 billion capped cannabis company that has eight licensed production facilities and operates in 18 countries.
The stock rose by over 14% on the back of the Peltz announcement and the news that he will work with Aurora to seal new co-operation agreements and expand globally.
Peltz said in a statement: “I believe Aurora has a solid execution track record, is strongly differentiated from its peers, has achieved integration throughout the value chain and is poised to go to the next level across a range of industry verticals. I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve.”
To see what Aurora executive chairman Michael Singer had to say about the appointment and the future of the cannabis industry click here.
Singer told Bllomberg: “Nelson comes with a phenomenal track record and was very excited about the growth opportunity here at Aurora. He isn’t as antagonistic as some of the market may portray him to be and he collaborates closely with the company’s board and management, and we thought that recipe and his deep connection to global businesses that we think are going to be value-added to our business going forward was the right recipe.”
Aurora said it will work “collaboratively and strategically to explore potential partnerships that would be the optimal strategic fit for successful entry into each of Aurora’s contemplated market segments.”
Peltz will receive 20 million options for shares at CAD10.34.
Big names are now being attracted to cannabis business pursuits. Martha Stewart and Snoop Dog are baking. Whoopi Goldberg and Melissa Etheridge have both put their money into medical cannabis based projects, Chelsea Handler was named a keynote speaker at the World Cannabis Congress in 2018 and recently invested in cannabis lifestyle company, Civilised. Then there’s Mike Tyson, Gene Simmons, Law & Order creator Dick Wolf, NBA star Cliff Robinson.
The cannabis revolution is coming, if it’s not already here and it seems like it could be a worthwhile investment.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
